Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Elife|June 4, 2017
Transcription factor <i>TFCP2L1</i> patterns cells in the mouse kidney collecting ductsMax Werth, Kai M Schmidt-Ott, Thomas Leete, et al.
JAMA|June 26, 2008
Intra-individual change over time in DNA methylation with familial clusteringHans T Bjornsson, Martin I Sigurdsson, M Daniele Fallin, et al.
Nature Communications|July 1, 2016
Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxiaXue Gao, Shu-Hai Lin, Feng Ren, et al.
Signal Transduction and Targeted Therapy|March 19, 2022
Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progressionShuai Yang, Yun Ling, Fang Zhao, et al.
Nature Medicine|January 18, 2011
The Ngal reporter mouse detects the response of the kidney to injury in real timeNeal Paragas, Andong Qiu, Qingyin Zhang, et al.
Ebiomedicine|February 6, 2022
SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer networkWei Li, Shuai Yang, Peng Xu, et al.
Oncology Research|September 28, 2019
Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres<sup>®</sup> in 275 Hepatocellular Carcinoma Patients: Results From the Chinese CalliSpheres<sup>®</sup> Transarterial Chemoembolization in Liver Cancer (CTILC) StudyJunhui Sun, Guanhui Zhou, Xiaoxi Xie, et al.
Medicine|March 21, 2020
Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients: A preliminary result from CTILC studyJun Luo, Jiaping Zheng, Changsheng Shi, et al.
Oncology Research|December 21, 2019
The Comprehensive Analysis of Efficacy and Safety of CalliSpheres<sup>®</sup> Drug-Eluting Beads Transarterial Chemoembolization in 367 Liver Cancer Patients: A Multiple-Center, Cohort StudyZhiyi Peng, Guohong Cao, Qinming Hou, et al.
Translational Cancer Research|February 4, 2022
Efficacy and safety of CalliSpheres<sup>®</sup> drug-eluting beads transarterial chemoembolization in patients with secondary liver cancer: a preliminary result from CTILC studyXia Wu, Shihong Ying, Jing Huang, et al.
Pageof 8